MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Richard S. Lindahl
Richard S. LindahlEMERGENT BIOSOLUTIONS INC

Richard S. Lindahl

Executive Vice President and CFO at EMERGENT BIOSOLUTIONS INC

Manager

Deal Bio

Total Deals2
Valued Deals2
Total Value£ 52 M
Avg. Deal Size£ 26 M

Market Context

Sort

20 Jun 2024|United States|Biotechnology
Emergent Biosolutions (baltimore-camden Manufacturing Site)
Bora Pharmaceuticals Co

Target: EMERGENT BIOSOLUTIONS (BALTIMORE-CAMDEN MANUFACTURING SITE)

Bidder: BORA PHARMACEUTICALS CO

5 Service Providers

2 Bidder | 3 Vendor

18 Dealmakers

2 Bidder | 16 Vendor

£ 23 M

Value

10 Mar 2025|United States|Pharmaceuticals
Emergent Biosolutions (baltimore-bayview Facility)
SYNGENE

Target: EMERGENT BIOSOLUTIONS (BALTIMORE-BAYVIEW FACILITY)

Bidder: SYNGENE

3 Service Providers

3 Vendor

12 Dealmakers

12 Vendor

£ 28 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite